Diagnosing fibromyalgia
is now as simple as a blood test.

Give your patients a definitive answer. And real hope.

As many as 28 million Americans have the chronic medical disease known as fibromyalgia. They suffer from a wide range of symptoms — and doctors struggle with lengthy and frustrating attempts to diagnose it. An estimated 95% of people with fibromyalgia remain undiagnosed today.

That’s about to change — thanks to the FM/a® Test and healthcare providers like you.

The science behind the solution.

The FM/a® Test identifies unique chemokine and cytokine protein patterns within the immune system’s white blood cells. The presence of fibromyalgia is documented when an irregular protein pattern is detected.

This breakthrough fibromyalgia blood test is the result of award-winning research and independent clinical studies performed at the University of Illinois College of Medicine at Chicago. The science behind the FM/a® Test has been peer-reviewed and published in leading medical journals. Learn more about the FM/a® Test and our ongoing research.

Ordering the FM/a® Test is fast and easy.

The FM/a® fibromyalgia blood test is quick, accurate, and requires less than a half-ounce of blood. It’s covered by Medicare and nearly all PPO insurance plans so there’s little or no cost to patients.

1. Determine if your patient is a candidate for the FM/a® Test.

People who are experiencing or have recently experienced at least four of these common fibromyalgia symptoms are good candidates.

2. Order the test.

Download the Licensed Healthcare Provider Authorization Form and follow the directions.

AUTHORIZATION FORM

IMPORTANT: Be sure to include the patient’s contact information (number & email) when you complete the authorization form.

3. We take it from there.

We’ll contact the patient, collect relevant medical history, confirm insurance coverage, and arrange for a blood draw at a local Quest lab or in the safety of their own home.

Patients with positive FM/a ® Test results will be invited to volunteer to participate in upcoming treatment trials.

Unlike any therapy today, this new treatment is designed to eliminate the symptoms of fibromyalgia without the negative side effects of current treatments.

Diagnosing fibromyalgia
is now as simple as a blood test.

Give your patients a definitive answer. And real hope.

As many as 28 million Americans have the chronic medical disease known as fibromyalgia. They suffer from a wide range of symptoms — and doctors struggle with lengthy and frustrating attempts to diagnose it. An estimated 95% of people with fibromyalgia remain undiagnosed today.

That’s about to change — thanks to the FM/a® Test and healthcare providers like you.

The science behind the solution.

The FM/a® Test identifies unique chemokine and cytokine protein patterns within the immune system’s white blood cells. The presence of fibromyalgia is documented when an irregular protein pattern is detected.

This breakthrough fibromyalgia blood test is the result of award-winning research and independent clinical studies performed at the University of Illinois College of Medicine at Chicago. The science behind the FM/a® Test has been peer-reviewed and published in leading medical journals. Learn more about the FM/a® Test and our ongoing research.

Ordering the FM/a® Test is fast and easy.

The FM/a® fibromyalgia blood test is quick, accurate, and requires less than a half-ounce of blood. It’s covered by Medicare and nearly all PPO insurance plans so there’s little or no cost to patients.

1. Determine if your patient is a candidate for the FM/a® Test.

People who are experiencing or have recently experienced at least four of these common fibromyalgia symptoms are good candidates.

2. Order the test.

Download the Licensed Healthcare Provider Authorization Form and follow the directions.

AUTHORIZATION FORM

IMPORTANT: Be sure to include the patient’s contact information (number & email) when you complete the authorization form.

3. We take it from there.

We’ll contact the patient, collect relevant medical history, confirm insurance coverage, and arrange for a blood draw at a local Quest lab or in the safety of their own home.

Patients with positive FM/a ® Test results will be invited to volunteer to participate in an FDA-approved clinical treatment trial at Harvard/Massachusetts General Hospital.

Unlike any therapy today, this new treatment is designed to change the biology of fibromyalgia and reverse its symptoms once and for all.